Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy-Reference-Cited by-同舟云学术

Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy

Published:2017-05-24 Issue:391 Volume:9 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Yang Katherine S.¹²^ORCID,Im Hyungsoon¹²^ORCID,Hong Seonki¹²^ORCID,Pergolini Ilaria³,del Castillo Andres Fernandez¹^ORCID,Wang Rui⁴⁵^ORCID,Clardy Susan¹²,Huang Chen-Han¹²,Pille Craig¹⁶^ORCID,Ferrone Soldano³,Yang Robert¹,Castro Cesar M.¹⁷^ORCID,Lee Hakho¹²,del Castillo Carlos Fernandez³⁷,Weissleder Ralph¹²⁸^ORCID

Affiliation:

1. Center for Systems Biology, Massachusetts General Hospital, Boston, MA 02114, USA.

2. Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, USA.

3. Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA.

4. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

5. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA.

6. Department of Health Sciences, Northeastern University, Boston, MA 02115, USA.

7. Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

8. Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.

Abstract

A multiplexed plasmonic assay analyzes circulating tumor-derived extracellular vesicles for detection of pancreatic ductal adenocarcinoma.

Funder

National Heart, Lung, and Blood Institute

National Cancer Institute

Lustgarten Foundation

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference41 articles.

1. Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials

2. Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature

3. Tumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: A meta-analysis;Zhang Y.;Int. J. Clin. Exp. Med.,2015

4. Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report

5. Precision medicine in pancreatic cancer — fact or fiction?

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering extracellular vesicles protein cargo in pancreatic cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Advances in new biomarkers for early diagnosis of pancreatic cancer;Suizo;2024-08-30

3. Recent advances in the development of multiplexed nanophotonic biosensors.;Photodiagnosis and Photodynamic Therapy;2024-08

4. Recent advances in plasmonics for liquid biopsy: A short review;Materials Today Communications;2024-08

5. The systematic role of pancreatic cancer exosomes: distant communication, liquid biopsy and future therapy;Cancer Cell International;2024-07-25